C07D 249/04
1,2,3-triazoles
Official title: 1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
C07D249/04 (1,2,3-triazoles) appears on 1,148 US grants and 1,320 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,148
- Published applications
- 1,320
- Assignees
- 703
- Inventors
- 4,281
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 19 | 0 |
| 1977 | 16 | 0 |
| 1978 | 8 | 0 |
| 1979 | 9 | 0 |
| 1980 | 8 | 0 |
| 1981 | 13 | 0 |
| 1982 | 10 | 0 |
| 1983 | 5 | 0 |
| 1984 | 10 | 0 |
| 1985 | 7 | 0 |
| 1986 | 9 | 0 |
| 1987 | 9 | 0 |
| 1988 | 6 | 0 |
| 1989 | 10 | 0 |
| 1990 | 6 | 0 |
| 1991 | 5 | 0 |
| 1992 | 5 | 0 |
| 1993 | 11 | 0 |
| 1994 | 9 | 0 |
| 1995 | 11 | 0 |
| 1996 | 7 | 0 |
| 1997 | 13 | 0 |
| 1998 | 5 | 0 |
| 1999 | 9 | 0 |
| 2000 | 14 | 0 |
| 2001 | 18 | 4 |
| 2002 | 17 | 11 |
| 2003 | 12 | 27 |
| 2004 | 10 | 28 |
| 2005 | 11 | 27 |
| 2006 | 15 | 39 |
| 2007 | 18 | 37 |
| 2008 | 12 | 29 |
| 2009 | 24 | 45 |
| 2010 | 35 | 71 |
| 2011 | 30 | 56 |
| 2012 | 43 | 64 |
| 2013 | 55 | 64 |
| 2014 | 70 | 62 |
| 2015 | 50 | 72 |
| 2016 | 53 | 71 |
| 2017 | 60 | 74 |
| 2018 | 59 | 64 |
| 2019 | 43 | 49 |
| 2020 | 50 | 63 |
| 2021 | 42 | 77 |
| 2022 | 44 | 63 |
| 2023 | 42 | 72 |
| 2024 | 37 | 61 |
| 2025 | 41 | 49 |
| 2026 | 23 | 41 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Substituted 1,2,3-triazoles as antibacterial and antifungal pleuromutilin conjugates6 Oct 2026US 12,753,177 B2Syddansk Universittet
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Composition for prevention or treatment of neurofibromatosis type 2 syndrome22 Sep 2026US 12,741,946 B2Prg S&Tech Inc.
- Probe directed to enzyme ALDH1A3 and use thereof in the diagnosis of glioblastoma15 Sep 2026US 12,734,254 B2Universita Degli Studi Del Piemonte Orientale “A. Avogadro”
- 18F-labeled triazole containing PSMA inhibitors14 Jul 2026US 12,679,812 B2Cornell University
- Compounds useful for in vivo imaging of protein oxidation and/or cancer treatment1 Oct 2026US 2026/0295098 A1Wake Forest University Health Sciences
- Therapeutic compounds1 Oct 2026US 2026/0297016 A1Regents of the University of Minnesota
- Synthetic methods of making (2h-1, 2, 3-triazol-2-yl) phenyl compounds as orexin receptor modulators1 Oct 2026US 2026/0297096 A1Janssen Pharmaceutica NV
- Antibiotics comprising lpxh-targeting compounds and methods of making and using the same24 Sep 2026US 2026/0285808 A1Duke University
- Crystalline forms of a 1h-1,2,3-triazole-4-carboxylic acid compound24 Sep 2026US 2026/0285817 A1
Most cited
By later US patents
- Copper-catalysed ligation of azides and acetylenes267US 7,375,234 B2The Scripps Research Institute · 2008
- Nitrogen containing heteroaromatics as factor Xa inhibitors211US 6,020,357 ADuPont Pharmaceuticals Company · 2000
- Compounds and compositions for intracellular delivery of therapeutic agents143US 9,868,691 B2ModernaTX, Inc. · 2018
- Medicaments for the treatment of disorders of lipometabolism and their use138US 4,405,644 ABayer Aktiengesellschaft · 1983
- Nitrogen-containing aromatic derivatives135US 7,253,286 B2Eisai Co., Ltd. · 2007